Pharmafile Logo
Pharmafocus logo
Advanced Search

Vernalis reassures investors on restructuring

February 4, 2004

News

Industry chair for communications body

February 3, 2004

Stuart Rose has been named as the new chair of the Healthcare Communications Association (HCA), the first ever from the …

News

AstraZeneca emerges unscathed from $2.6 billion patent loss

February 3, 2004

Strong growth in a new generation of products has helped AstraZeneca earn a memorable victory in overcoming $2.6 billion worth …

News

Managing medical education

February 3, 2004

Over the years, Medical Education (med ed) and PR agencies have been an invaluable part of the marketing mix. Med …

Feature

Cambridge abandons neuroscience centre plans

January 29, 2004

News

Sanofi makes takeover bid for ‘weakened’ Aventis

January 26, 2004

Sanofi-Synthelabo has made a pre-emptive E47 billion takeover bid for Aventis with the aim of creating the world's third-biggest drugmaker …

News

Commission restates its support for parallel trade

January 23, 2004

News

Pfizer takes giant step forward

January 23, 2004

The pharmaceutical industry's biggest company Pfizer has restated its dominance with renewed growth in sales and earnings for the fourth …

News

Abbott raises sales expectations for Humira

January 21, 2004

Abbott Laboratories has raised its sales forecast for Humira, its new rheumatoid arthritis treatment, to $700 million in 2004 after …

News

Pfizer to sell diagnostics business

January 21, 2004

Pfizer has agreed to sell its Swedish in-vitro allergy and autoimmune diagnostic business to private equity groups Triton and PPM …

News

Aventis and Sanofi attempt to quash merger rumours

January 19, 2004

Sanofi-Synthelabo and Aventis have been forced to officially deny they are in merger talks after speculation sent shares soaring in …

News

Streamlined research

January 19, 2004

For many years the pharmaceutical industry has been promising that they were on the verge of a boom in the …

Feature

Sizing up med ed

January 19, 2004

The use of medical education in the pharmaceutical industry has never been greater. Starting from the early stages of clinical …

Feature

Too close for comfort?

January 19, 2004
Medical Communications, Sales and Marketing doctors, industry reputation

The pharmaceutical industry's increasing scale and influence means that no part of its conduct is above scrutiny, and criticism of …

Feature

Pfizer to sell-off sixty OTC products in Europe

January 16, 2004

Pfizer is looking to sell off about 60 non-core consumer products in Europe to position the business for long-term growth …

News

Eloxatin approved in US as first line treatment

January 16, 2004

Sanofi-Synthelabo's Eloxatin has received US approval for use as first line treatment of colorectal cancer in combination with standard treatment …

News

W.A.R marshals forces for healthcare push

January 16, 2004

Independent marketing communications agency Ware Anthony Rust has consolidated its healthcare accounts into a new division prompted by the sector's …

News

Genzyme to set up research facility in UK

January 16, 2004

Genzyme, one of the US' most successful biotechnology companies has chosen Cambridge as the location of its first research centre …

News

Renal care standards unveiled

January 15, 2004

News

More states defy FDA warnings on re-imports

January 15, 2004

A number of states and cities are drawing up plans to import medicines from Canada in open defiance of the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026